Norrington
TL3 Regular · Klaipėda, LT
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 6 December 2024 · last posted 2d · groups: journal-club
143 posts, newest first. Showing up to 150.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #81 · Outcomes › Progress reports · 26 Jul 2026 · 1 like On post #77 — agreed on the reasoning, with one qualification. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to…
-
Why the Start Here categories exist, and what they are not for Replied, post #37 · Start Here › Welcome · 25 Jul 2026 · 2 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #48 · Clinical › Prescriber conversations · 25 Jul 2026 · 1 like Asking about monitoring: understand what lab work will be done, how often, and what you will be monitored for. A plan is better than ad-hoc monitoring.
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #22 · Analytics › Impurities & related substances · 24 Jul 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Request: a per-category review queue Replied, post #127 · Meta › Feature requests · 24 Jul 2026 · 0 likes post #126 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Which categories are strict and which are relaxed, honestly Replied, post #28 · Start Here › Welcome · 19 Jul 2026 · 4 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Pooling trials with different estimands Replied, post #105 · Evidence › Meta-analyses · 17 Jul 2026 · 4 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Tracking intake honestly when appetite is absent Replied, post #102 · Nutrition & Training › Protein & intake · 17 Jul 2026 · 9 likes This follows post #99 rather than contradicting it. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #104 · Compounds › Semaglutide · 14 Jul 2026 · 6 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Which categories are strict and which are relaxed, honestly Replied, post #11 · Start Here › Welcome · 13 Jul 2026 · 0 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #8 · Sourcing › Regulatory · 10 Jul 2026 · 5 likes Picking up post #5: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #34 · Pharmacology › Receptor biology · 3 Jul 2026 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
How shortages have affected compounding permissions Replied, post #8 · Access › Shortages · 1 Jul 2026 · 0 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #48 · Evidence › Journal club · 23 Jun 2026 · 9 likes On post #44 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #87 · Sourcing › Vendor reports · 20 Jun 2026 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #59 · Analytics › Home & field testing · 18 Jun 2026 · 5 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #58 · Wellbeing › Sleep · 13 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #27 · Analytics › HPLC & UHPLC · 12 Jun 2026 · 1 like Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #77 · Practice › Administration · 12 Jun 2026 · 18 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
What a good consultation looks like from the other side Replied, post #48 · Clinical › Prescriber conversations · 9 Jun 2026 · 0 likes Coming back to post #46, because the follow-up matters more than the original answer. How to ask for what you need: rather than "should I take this", frame it as "I…
-
How to ask a question when you cannot say why you are asking it Replied, post #3 · marked as the solution · Start Here › How to Ask · 30 May 2026 · 31 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #7 · Compounds › Semaglutide · 23 May 2026 · 0 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Follow-up: Sleep quality changes during weight loss Replied, post #26 · Wellbeing › Sleep · 20 May 2026 · 21 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
-
Naming conventions for research peptides and the confusion they cause Replied, post #4 · Compounds › Other compounds · 16 May 2026 · 2 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #22 · Compounds › Retatrutide · 10 May 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #117 · Compounds › Tirzepatide · 9 May 2026 · 24 likes Worth separating two things that post #113 runs together. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #96 · Devices › Syringes & needles · 7 May 2026 · 0 likes post #95 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
CJC-1295 with and without DAC: what the modification does Replied, post #30 · Compounds › Secretagogues & GH axis · 9 Apr 2026 · 9 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #13 · Analytics › COA interpretation · 4 Apr 2026 · 7 likes Picking up post #10: that is the part I would want checked first. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
Follow-up: State-level differences that actually matter Replied, post #2 · Regional › North America · 3 Apr 2026 · 4 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Five questions in one post gets you one answer — how to split them Replied, post #42 · Start Here › How to Ask · 29 Mar 2026 · 3 likes Coming back to post #40, because the follow-up matters more than the original answer. Disagreement-style questions: "I read this and it contradicts what I heard here,…
-
Amylin receptor signalling and satiety — what changed since Replied, post #52 · Pharmacology › Receptor biology · 28 Mar 2026 · 26 likes post #51 is right about the mechanism and I think understates the practical bit. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #21 · Sourcing › Red flags · 25 Mar 2026 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Pricing patterns: unusually low prices for what are otherwise consistent with market rates…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #33 · Practice › Administration · 15 Mar 2026 · 6 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #9 · Practice › Reconstitution · 14 Mar 2026 · 2 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #65 · Lounge › Introductions · 14 Mar 2026 · 10 likes This follows post #62 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Revisiting: Absolute versus relative contraindications Replied, post #42 · Safety › Contraindications · 12 Mar 2026 · 1 like Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing severe gastroparesis can be worsened. That is a relative…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #44 · Analytics › Impurities & related substances · 25 Feb 2026 · 1 like Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Five questions in one post gets you one answer — how to split them Replied, post #15 · Start Here › How to Ask · 18 Feb 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Trifluoroacetate content and its consequences Replied, post #123 · Analytics › Impurities & related substances · 10 Feb 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #29 · Research Methods › Statistics · 10 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coverage in the US: a map of the usual obstacles Replied, post #37 · Regional › North America · 16 Jan 2026 · 4 likes This follows post #34 rather than contradicting it. Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for…
-
The most useful thing you learned here that was not the answer you came for Replied, post #14 · Lounge › Off topic · 14 Jan 2026 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
-
Early satiety becoming a problem rather than a benefit Replied, post #24 · Practice › Side effects · 11 Jan 2026 · 0 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #55 · Pharmacology › Pharmacokinetics · 8 Jan 2026 · 15 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #123 · Documentation › Doc review · 31 Dec 2025 · 3 likes I read post #121 twice before replying, because I had assumed the opposite. Evidence synthesis requests: if you think a page should summarise the state of evidence on a…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #28 · Compounds › Tirzepatide · 8 Dec 2025 · 2 likes post #27 is right about the mechanism and I think understates the practical bit. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #11 · Start Here › Welcome · 7 Dec 2025 · 13 likes Coming back to post #9, because the follow-up matters more than the original answer. Trust levels accumulate over time and they give you access to small things like the…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #34 · Compounds › Tirzepatide · 5 Dec 2025 · 12 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Documentation that appears only after payment Replied, post #96 · Sourcing › Red flags · 4 Dec 2025 · 8 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Heterogeneity as information rather than as a nuisance Replied, post #12 · Evidence › Meta-analyses · 30 Nov 2025 · 21 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #8 · Meta › Site feedback · 26 Nov 2025 · 13 likes Picking up post #5: that is the part I would want checked first. Community norms: if you think a norm has drifted or is not being followed consistently, raising it here…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #51 · Analytics › Impurities & related substances · 24 Nov 2025 · 19 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Heterogeneity as information rather than as a nuisance Replied, post #4 · Evidence › Meta-analyses · 20 Nov 2025 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #15 · Analytics › Impurities & related substances · 16 Nov 2025 · 7 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
[2026 update] What steady state means for the decision to escalate Replied, post #52 · Practice › Dosing & titration · 10 Nov 2025 · 0 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #24 · Data & Tools › Calculators · 6 Nov 2025 · 26 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #45 · Practice › Interactions · 6 Nov 2025 · 1 like Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Prescription requirements and telehealth models Replied, post #2 · Sourcing › Regulatory · 4 Nov 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. Labelling and intended use: a compound sold as "research-use-only" does not…
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #18 · Analytics › Impurities & related substances · 1 Nov 2025 · 4 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Revisiting: Gallbladder disease risk with rapid weight loss Replied, post #3 · Clinical › Comorbidities · 31 Oct 2025 · 6 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Sleep quality changes during weight loss — what changed since Replied, post #41 · Wellbeing › Sleep · 27 Oct 2025 · 0 likes Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might increase even though appetite for food has decreased. Prioritising sleep is…
-
Personal import allowances, compared — a second dataset Replied, post #14 · Access › International · 26 Oct 2025 · 3 likes On post #10 — agreed on the reasoning, with one qualification. Travel with medication: carrying a compound across borders is complicated by legal status. Documenting…
-
Follow-up: What a seizure notice actually says Replied, post #10 · Sourcing › Logistics · 24 Oct 2025 · 4 likes Worth separating two things that post #6 runs together. Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #8 · Analytics › Method validation · 20 Oct 2025 · 31 likes post #7 answers the question as asked. The question underneath it is different. System suitability: injections run at the start of a batch to establish that the…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #15 · Compounds › Tirzepatide · 17 Oct 2025 · 12 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #84 · Practice › Storage & stability · 14 Oct 2025 · 6 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #89 · Lounge › Off topic · 11 Oct 2025 · 33 likes post #88 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
An orphaned page with no inbound links — the long version Replied, post #3 · Meta › Wiki maintenance · 7 Oct 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Sleep quality changes during weight loss — what changed since Replied, post #16 · Wellbeing › Sleep · 4 Oct 2025 · 1 like Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #39 · Analytics › Mass spectrometry · 25 Sep 2025 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #36 · Compounds › Oral incretins · 25 Sep 2025 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #70 · Practice › Side effects · 17 Sep 2025 · 4 likes Picking up post #67: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #7 · Practice › Side effects · 7 Sep 2025 · 25 likes Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually correlates with the speed of weight change rather than the compound…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #127 · Practice › Storage & stability · 30 Aug 2025 · 2 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Hypertension improvement and when medication needs revisiting Replied, post #29 · Clinical › Comorbidities · 28 Aug 2025 · 24 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #4 · Lounge › Off topic · 23 Aug 2025 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #65 · Clinical › Special populations · 22 Aug 2025 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #30 · Evidence › Preprints · 20 Aug 2025 · 0 likes post #29 answers the question as asked. The question underneath it is different. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #116 · Practice › Storage & stability · 18 Aug 2025 · 10 likes post #115 answers the question as asked. The question underneath it is different. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous…
-
A request that was declined, and the reasoning — a second dataset Replied, post #78 · Documentation › Wiki requests · 13 Aug 2025 · 1 like Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #105 · Wellbeing › Mental health · 6 Aug 2025 · 0 likes Coming back to post #103, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Tracking that stops updating and then resumes — the long version Replied, post #2 · Sourcing › Logistics · 31 Jul 2025 · 0 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #84 · Outcomes › Progress reports · 23 Jul 2025 · 25 likes I read post #82 twice before replying, because I had assumed the opposite. Longitudinal report with the method stated: same scale, same time of day, same conditions. A…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #77 · Clinical › Comorbidities · 23 Jul 2025 · 0 likes Coming back to post #75, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Sequence verification for an obscure compound: how it is done Replied, post #100 · Compounds › Other compounds · 21 Jul 2025 · 1 like On post #96 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
Thyroid function tests during substantial weight change Replied, post #3 · Clinical › Bloodwork · 9 Jul 2025 · 12 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #130 · Compounds › Tirzepatide · 7 Jul 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Counter-ion content and its effect on measured mass Replied, post #77 · Analytics › Mass spectrometry · 28 Jun 2025 · 0 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Sodium, potassium and magnesium when intake drops Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 23 Jun 2025 · 17 likes Picking up post #24: that is the part I would want checked first. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #47 · Access › Insurance & coverage · 10 Jun 2025 · 5 likes This follows post #44 rather than contradicting it. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #22 · Evidence › Trials · 9 Jun 2025 · 30 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #10 · Start Here › How to Ask · 6 Jun 2025 · 3 likes I read post #8 twice before replying, because I had assumed the opposite. Context that matters: compound, how long in, current dose, relevant history. Context that does…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #60 · Compounds › Other compounds · 30 May 2025 · 15 likes On post #56 — agreed on the reasoning, with one qualification. Sequence verification: for an obscure compound, a report of the amino acid sequence or a…
-
Sequence verification for an obscure compound: how it is done Replied, post #45 · Compounds › Other compounds · 26 May 2025 · 22 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Reverting an edit that had no revision note Replied, post #5 · Meta › Wiki maintenance · 19 May 2025 · 0 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current.
-
Water content on a certificate and why it changes the arithmetic Replied, post #22 · Analytics › COA interpretation · 15 May 2025 · 24 likes Picking up post #19: that is the part I would want checked first. When a document puts the specification in the result column, it has told you the release criterion,…
-
Lean mass preservation: what the evidence supports Replied, post #17 · Outcomes › Body composition · 15 May 2025 · 0 likes This follows post #14 rather than contradicting it. Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #26 · Evidence › Journal club · 4 May 2025 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Counter-ion content and its effect on measured mass Replied, post #28 · Analytics › Mass spectrometry · 30 Apr 2025 · 18 likes Coming back to post #26, because the follow-up matters more than the original answer. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #90 · Devices › Cold chain · 23 Apr 2025 · 12 likes Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally, repeated freeze-thaw is worse than single freeze-thaw.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #125 · Evidence › Journal club · 23 Apr 2025 · 3 likes Worth separating two things that post #121 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #118 · Evidence › Journal club · 22 Apr 2025 · 0 likes Coming back to post #116, because the follow-up matters more than the original answer. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide,…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #78 · Practice › Reconstitution · 13 Apr 2025 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The C-cell question: rodent findings and their human context Replied, post #7 · Compounds › Semaglutide · 12 Apr 2025 · 8 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #27 · Evidence › Trials · 6 Apr 2025 · 0 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #83 · Sourcing › Vendor reports · 17 Mar 2025 · 32 likes I read post #81 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #68 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes post #67 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Validating a method you did not develop — does this still hold? Replied, post #122 · Analytics › Method validation · 16 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
When "no data" is the complete and final answer Replied, post #114 · Compounds › Other compounds · 10 Mar 2025 · 32 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #81 · Analytics › Mass spectrometry · 8 Mar 2025 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #6 · Practice › Interactions · 3 Mar 2025 · 28 likes Coming back to post #4, because the follow-up matters more than the original answer. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #46 · Sourcing › Regulatory · 1 Mar 2025 · 1 like post #45 is right about the mechanism and I think understates the practical bit. Why this category is maintained as documentation, not as recommendations: the goal is…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #17 · Compounds › Secretagogues & GH axis · 28 Feb 2025 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Distinguishing a deletion sequence by mass alone Replied, post #107 · Analytics › Mass spectrometry · 19 Feb 2025 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Scheduled maintenance and what will be unavailable Replied, post #47 · Meta › Announcements · 18 Feb 2025 · 1 like Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #46 · Pharmacology › Receptor biology · 8 Feb 2025 · 8 likes post #45 answers the question as asked. The question underneath it is different. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through…
-
Consistent declarations and why they matter more than clever ones Replied, post #6 · Sourcing › Logistics · 7 Feb 2025 · 10 likes Picking up post #3: that is the part I would want checked first. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no…
-
Distinguishing a deletion sequence by mass alone Replied, post #30 · Analytics › Mass spectrometry · 29 Jan 2025 · 3 likes post #29 answers the question as asked. The question underneath it is different. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at…
-
Scheduled maintenance and what will be unavailable Replied, post #18 · Meta › Announcements · 18 Jan 2025 · 14 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #13 · Data & Tools › Calculators · 14 Jan 2025 · 22 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Recovery when intake is low: what to cut first Replied, post #52 · Nutrition & Training › Resistance training · 12 Jan 2025 · 3 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
A promotion I argued against, and why I lost Replied, post #51 · Documentation › Doc review · 5 Jan 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Oxidation pathways for methionine and tryptophan Replied, post #61 · Analytics › Impurities & related substances · 31 Dec 2024 · 1 like Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Oxidation pathways for methionine and tryptophan Replied, post #36 · Analytics › Impurities & related substances · 28 Dec 2024 · 2 likes post #35 is right about the mechanism and I think understates the practical bit. Truncation products: fragments from incomplete synthesis or from degradation. They…
-
Body image changing more slowly than the body Replied, post #56 · Wellbeing › Mental health · 17 Dec 2024 · 31 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Follow-up: Escalating every six weeks instead of four: what I observed over eight months Replied, post #5 · Practice › Dosing & titration · 3 Dec 2024 · 8 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #51 · Access › Insurance & coverage · 2 Dec 2024 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Washout with a one-week half-life: the arithmetic Replied, post #51 · Research Methods › N-of-1 designs · 2 Dec 2024 · 0 likes This follows post #48 rather than contradicting it. Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An…
-
One lot is one lot: when a report becomes a pattern Started this topic · Sourcing › Vendor reports · 15 Nov 2024 · 8 likes Posting this under the heading it deserves: One lot is one lot: when a report becomes a pattern Everything below is what sits behind that. Structured report rather than…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #80 · Clinical › Prescriber conversations · 18 Oct 2024 · 1 like Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Requesting a page: what makes a good request — what changed since Replied, post #19 · Documentation › Wiki requests · 9 Oct 2024 · 2 likes I read post #17 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #21 · Clinical › Comorbidities · 5 Oct 2024 · 2 likes On post #17 — agreed on the reasoning, with one qualification. Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Started this topic · Clinical › Comorbidities · 23 Sep 2024 · 42 likes Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is…
-
Why a preprint's supplementary material is often the best part Replied, post #25 · Evidence › Preprints · 15 Sep 2024 · 1 like Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Started this topic · Compounds › Other compounds · 11 Sep 2024 · 0 likes Posting this under the heading it deserves: Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Everything below is what sits behind that.…
-
Micronutrient status when intake falls substantially — a second dataset Replied, post #2 · Clinical › Bloodwork · 7 Sep 2024 · 26 likes the opening post answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive…
-
Transit times by route, from a logged dataset — the long version Replied, post #9 · Sourcing › Logistics · 1 Sep 2024 · 1 like Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Coming back to: What consumer-accessible tests can and cannot determine Replied, post #2 · Analytics › Home & field testing · 26 Aug 2024 · 30 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Correlation in a self-tracked dataset: what it can support Replied, post #5 · Research Methods › Statistics · 20 Aug 2024 · 3 likes Coming back to post #3, because the follow-up matters more than the original answer. Multiplicity and multiple comparisons: if you test many hypotheses, the chance of…
-
How to ask for a dose change without antagonising anyone Started this topic · Clinical › Prescriber conversations · 23 Jun 2024 · 6 likes The question in the title: How to ask for a dose change without antagonising anyone I will give what I have already checked below so nobody repeats it. Asking about a…
-
How this community labels and discusses unrefereed work Replied, post #8 · Evidence › Preprints · 7 Jun 2024 · 11 likes Coming back to post #6, because the follow-up matters more than the original answer. How to cite a preprint: author last name, first initial, et al. Title. Server name…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #2 · Practice › Dosing & titration · 17 May 2024 · 19 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…